Latest News
Kantaro Biosciences signs marketing agreement for COVID-SeroKlir and COVID-SeroIndex with EKF Diagnostics
29 October 2020 - Kantaro Biosciences LLC and its manufacturing partner Bio -Techne Corporation (NASDAQ:TECH ) on Wednesday entered into a two-year marketing and distribution agreement of its COVID-SeroKlir and COVID-SeroIndex with EKF Diagnostics, a...
Agena Bioscience awarded FDA's EUA for high-throughput, low-cost SARS-CoV-2 panel
29 October 2020 - Genetic analysis systems company Agena Bioscience reported on Wednesday the receipt of the Emergency Use Authorization from the US Food and Drug Administration (FDA) for its MassARRAY SARS-CoV-2 Panel for qualitative detection of th...
CStone Pharmaceuticals signs licensing agreement with LegoChem Biosciences
29 October 2020 - CStone Pharmaceuticals (HKEX: 2616), a China-based biopharmaceutical company, has signed a licensing agreement with LegoChem Biosciences Inc (LCB)(KOSDAQ:141080), a Korea-based clinical-stage biopharmaceutical company, it was report...
PeproMene Bio submits US FDA Investigational New Drug application to study PMB-101
29 October 2020 - United States-based PeproMene Bio Inc has submitted an Investigational New Drug (IND) application to the United States Food and Drug Administration (FDA) to study a novel chimeric antigen receptor (CAR) T cell therapy, PMB-101, it w...
Samsung Biologics open's first US CDO R&D Centre in San Francisco
29 October 2020 - Samsung Biologics (KRX: 207940.KS), a publicly-traded biotechnology company, is opening its first US CDO (contract diagnostic organisation) R&D Centre in San Francisco, it was reported on Wednesday.With its new facility, the fir...